Conference Information

Welcome Message

Greeting of the day!

The “3rd International Conference on Pathology and Surgical Pathology”, scheduled for November 16–17, 2026 in London, UK, brings together global experts to explore these developments and their impact on contemporary healthcare.

Theme: The Art of Precision, the Science of Healing

The evolving landscape of pathology continues to redefine modern medicine through deeper insights into disease at the molecular, cellular, and tissue levels. Advances in DNA research are transforming our understanding of disease mechanisms, while innovations in blood, serum, and plasma-based diagnostics are enabling earlier and more accurate detection of clinical conditions.

This scientific gathering will highlight progress in surgical pathology and tissue-based diagnosis, along with emerging applications of stem cell science in regenerative medicine and surgical innovation. The integration of pathology with modern medicine continues to strengthen the bridge between laboratory discovery and clinical decision-making.

Discussions will focus on how evolving diagnostic tools and technologies are improving precision in patient care, supporting more targeted and effective treatment approaches.

We welcome you to join this global platform of knowledge exchange and scientific collaboration as we shape the future of pathology and surgical pathology.

Best Regards,
Sanem Channing
Program Director | Pathology2026
pathology@alliedconference.org

About the Conference

The 3rd International Conference on Pathology and Surgical Pathology, scheduled for November 16–17, 2026 in London, UK, is a global platform focused on advancing modern diagnostic science and clinical integration.

The conference brings together experts in pathology, surgical pathology, DNA-based diagnostics, blood and plasma analysis, serum biomarkers, tissue science, stem cell research, and clinical medicine to discuss recent developments shaping disease diagnosis and management.

It promotes knowledge exchange on emerging technologies that are improving diagnostic accuracy, supporting faster decision-making, and strengthening the link between laboratory findings and patient care.

Target Audience

Pathologists (Anatomic & Clinical)
Clinical Microbiologists
Hematologists & Hematopathologists
Biomedical Scientists & Laboratory Technologists
Professors and Students of Pathology
Molecular Diagnostic Researchers
Clinical Biochemists
Diagnostic Laboratory Directors
Pharmaceutical & Diagnostic Industry Professionals
Medical Device & IVD Manufacturing Companies

Why to Attend

This Conference offers insights into the latest advances in molecular diagnostics, tissue pathology, liquid biopsy approaches, stem cell applications, and surgical pathology innovations. It provides a space to connect with global experts, share research, and explore new directions in diagnostic medicine.

Participants will benefit from updated scientific knowledge, collaborative opportunities, and exposure to emerging tools that are shaping the future of pathology and clinical practice.

Scientific Sessions

1. Pathology

At Pathology 2026, Study of disease mechanisms through examination of tissues, organs, and bodily fluids. It focuses on identifying structural and functional changes that occur in disease states.
Forms the foundation of precision diagnosis, enabling the art of precision in healing

Key Highlights:
1.1 Disease morphology assessment
1.2 Tissue-based diagnosis
1.3 Cancer classification systems
1.4 Inflammation profiling
1.5 Diagnostic accuracy enhancement

Related Conference

Related Journals

2. Surgical Pathology

At Pathology 2026, Examination of tissues removed during surgery to diagnose disease.It provides critical intraoperative and post-operative diagnostic insights.
Guides precise surgical decisions for scientifically driven healing outcomes

Key Highlights:
2.1 Intraoperative diagnosis
2.2 Tumor margin evaluation
2.3 Biopsy interpretation
2.4 Frozen section analysis
2.5 Surgical decision support

Related Conference

Related Journals

3. Genomic Pathology

At Pathology 2026, Integration of genomic data into disease diagnosis and classificationIt links molecular genetic alterations with disease behaviour and outcomes.
Enables precision healing through molecular-level disease understanding.

Key Highlights:
3.1 Gene mutations profiling
3.2 Cancer genome mapping
3.3 Personalized diagnostics
3.4 Molecular classification
3.5 Targeted therapy guidance

Related Conference

Related Journals

4. DNA Dynamics

At Pathology 2026, Study of structural and functional changes in DNA under disease conditions. It explores how DNA alterations influence disease progression and repair. Reveals precision insights into disease evolution and repair mechanisms

Key Highlights:
4.1 DNA replication errors
4.2 Epigenetic modifications
4.3 Mutation tracking
4.4 Genome instability analysis
4.5 Repair pathway assessment

Related Conference

Related Journals

5. Liquid Biopsies

At Pathology 2026, Minimally invasive testing using blood or fluids to detect disease markersIt enables detection of circulating biomarkers without surgical intervention. Enhances precision detection without surgical intervention

Key Highlights:
5.1 Circulating tumor DNA
5.2 Exosome analysis
5.3 Real-time monitoring
5.4 Early cancer detection
5.5 Treatment response tracking

Related Conference

Related Journals

6. Blood Biomarkers

At Pathology 2026, Biological indicators in blood reflecting disease presence or progression. They provide measurable signals of physiological and pathological changes. Enables early precision-based disease identification

Key Highlights:
6.1 Protein marker analysis
6.2 Enzyme level tracking
6.3 Disease staging indicators
6.4 Prognostic evaluation
6.5 Screening applications

Related Conference

Related Journals

7. Serum Signatures

At Pathology 2026, Pattern-based profiling of serum components linked to disease states. It identifies unique molecular patterns associated with specific conditions. Supports refined diagnostic precision through molecular signatures.

Key Highlights:
7.1 Protein expression patterns
7.2 Immune response markers
7.3 Cancer signature mapping
7.4 Diagnostic fingerprinting
7.5 Predictive modelling

Related Conference

Related Journals

8. Plasma Profiling

At Pathology 2026, Comprehensive analysis of plasma components for clinical insights. It evaluates proteins, metabolites, and circulating molecules in blood plasma. Advances precision diagnostics through systemic biological mapping

Key Highlights:
8.1 Metabolite profiling
8.2 Circulating RNA analysis
8.3 Protein quantification
8.4 Disease biomarker discovery
8.5 Therapeutic monitoring

Related Conference

Related Journals

9. Cellular Medicine

At Pathology 2026, Study and application of cellular-level therapies in disease management. It focuses on manipulating cells to restore normal biological function.
Delivers healing through targeted cellular precision interventions.

Key Highlights:
9.1 Cell therapy design
9.2 Immune cell engineering
9.3 Regenerative applications
9.4 Cellular diagnostics
9.5 Tissue repair mechanisms

Related Conference

Related Journals

10. Tissue Engineering

At Pathology 2026, Development of biological substitutes to restore damaged tissues. it combines biology and engineering to rebuild functional tissue structures.
Enables reconstructive precision in healing damaged organs

Key Highlights:
10.1 Scaffold design
10.2 Biomaterial integration
10.3 3D tissue fabrication
10.4 Regeneration modeling
10.5 Organ replacement research

Related Conference

Related Journals

11. Stem Therapeutics

At Pathology 2026, Use of stem cells for regeneration and disease treatment.It utilizes stem cell potential to repair and regenerate damaged tissues.
Promotes regenerative precision in healing complex disorders

Key Highlights:
11.1 Stem cell differentiation
11.2 Regenerative therapy
11.3 Tissue repair mechanisms
11.4 Cellular reprogramming
11.5 Clinical stem applications

Related Conference

Related Journals

12. Regenerative Pathology

At Pathology 2026, Study of tissue repair, regeneration, and healing processes in disease. It examines how tissues recover and regenerate after injury or disease.
Bridges pathology with healing science for precision recovery

Key Highlights:
12.1 Wound healing pathways
12.2 Fibrosis analysis
12.3 Regeneration biology
12.4 Cellular restoration
12.5 Healing biomarkers

Related Conference

Related Journals

13. Surgery

At Pathology 2026, Medical specialty focused on operative treatment of diseases.It involves manual and technological interventions to treat pathological conditions. Translates diagnostic precision into therapeutic healing action

Key Highlights:
13.1 Minimally invasive techniques
13.2 Oncological surgery
13.3 Robotic-assisted procedures
13.4 Surgical precision tools
13.5 Post-operative recovery

Related Conference

Related Journals

14. Digital Pathology

At Pathology 2026, Use of digital imaging and AI for pathology diagnosis. It transforms traditional pathology slides into digital data for analysis.
Enhances precision diagnostics through digital intelligence

Key Highlights:
14.1 Whole slide imaging
14.2 AI-based diagnosis
14.3 Remote pathology access
14.4 Image analysis automation
14.5 Data-driven reporting

Related Conference

Related Journals

15. Predictive Oncology

At Pathology 2026, Use of predictive models to forecast cancer progression and outcomes. It applies data analytics and AI to anticipate disease behaviour.
Enables precision forecasting for personalized cancer care

Key Highlights:
15.1 Risk modelling
15.2 Treatment prediction
15.3 Survival analytics
15.4 AI oncology tools
15.5 Response forecasting

Related Conference

Related Journals

16. Diagnostic Innovations

At Pathology 2026, New technologies and methods improving disease detection. It focuses on developing advanced tools for faster and accurate diagnosis.
Drives precision diagnosis through innovative scientific tools

Key Highlights:
16.1 AI diagnostics
16.2 Point-of-care testing
16.3 Molecular imaging
16.4 Rapid screening tools
16.5 Smart biosensors

Related Conference

Related Journals

17. Necrosis and Repair

At Pathology 2026, Study of tissue death and subsequent healing mechanisms. It examines how damaged tissues undergo death and recovery processes.
Explains precision balance between damage and recovery.

Key Highlights:
17.1 Cell death pathways
17.2 Tissue regeneration
17.3 Inflammatory response
17.4 Healing cascade
17.5 Repair biomarkers

Related Conference

Related Journals

18. Organ Dysfunction

At Pathology 2026, Study of impaired organ function due to disease or injury. It focuses on how organs lose function and respond to pathological stress.
Enables precision targeting of organ-specific healing strategies.

Key Highlights:
18.1 Functional decline analysis
18.2 Multi-organ failure mechanisms
18.3 Biomarker correlation
18.4 Disease progression tracking
18.5 Therapeutic intervention points

Related Conference

Related Journals

19. Metabolic Toxicity

At Pathology 2026, Harmful effects of metabolic imbalance and toxic accumulation. It studies how metabolic disturbances lead to cellular and organ damage.
Supports precision detection of metabolic disruption in disease.

Key Highlights:
19.1 Metabolic pathway disruption
19.2 Toxic metabolite build-up
19.3 Cellular stress response
19.4 Liver/kidney toxicity markers
19.5 Detoxification pathways

Related Conference

Related Journals

20. Xenobiotic

At Pathology 2026, Study of foreign chemical substances in the body and their effects. It analyses how external compounds are metabolized and eliminated.
Enhances precision toxicology in disease prevention and treatment.

Key Highlights:
20.1 Drug metabolism
20.2 Chemical toxicity
20.3 Detoxification enzymes
20.4 Exposure analysis
20.5 Pharmacokinetics

Related Conference

Related Journals

21. Case Studies

At Pathology 2026, Real-world clinical cases used for research and learning in medicine. It presents documented patient scenarios for clinical understanding.
Strengthens precision medicine through evidence-based learning.

Key Highlights:
21.1 Clinical pattern recognition
21.2 Rare disease documentation
21.3 Treatment outcome analysis
21.4 Diagnostic challenges
21.5 Evidence-based insights

Related Conference

Related Journals

Market Analysis

Overview

The global anatomic and surgical pathology market is valued at around USD 41.6 billion and is projected to reach USD 71.7 billion by 2033, growing at a strong ~8.1% CAGR.
Growth is supported by rising cancer prevalence, aging populations, and increasing demand for precise diagnostics.

Other key estimates reinforce expansion:

Anatomic pathology market: USD 13.3B (2024) → USD 19.4B (2035) at 3.49% CAGR

Pathological examination market: USD 468.79M (2025) → USD 1,316.75M (2033) at 13.78% CAGR

Overall, the sector shows steady to high growth driven by technological and clinical demand.

Regional Outlook

Asia-Pacific: Fastest growth region

India: 6.5% CAGR

China: 6.1% CAGR
Driven by expanding healthcare systems and rising diagnostic demand.

North America: Largest market share due to advanced infrastructure and early technology adoption.

Europe: Stable growth supported by strong oncology and research frameworks.

Emerging regions: Gradual expansion through healthcare modernization.

Current Challenges

Shortage of trained pathologists
High cost of digital pathology systems
Uneven healthcare infrastructure in developing countries
Regulatory and compliance barriers
Data handling challenges in digital diagnostics

Future Outlook

Growth of AI-based pathology and automation
Expansion of digital and remote diagnostics (telepathology)
Rising demand for precision medicine and molecular testing
Increased lab automation improving efficiency and accuracy
Strong expansion in emerging economies

3rd International Conference on
Pathology and Surgical Pathology

Quick Links

Theme: The Art of Precision, the Science of Healing

Conference Information

Welcome Message

About the Conference

Scientific Sessions

6. Blood Biomarkers

7. Serum Signatures

8. Plasma Profiling

9. Cellular Medicine

10. Tissue Engineering

11. Stem Therapeutics

12. Regenerative Pathology

13. Surgery

14. Digital Pathology

15. Predictive Oncology

16. Diagnostic Innovations

17. Necrosis and Repair

18. Organ Dysfunction

19. Metabolic Toxicity

20. Xenobiotic

21. Case Studies

Market Analysis